Page last updated: 2024-10-31

nafamostat and Peritoneal Neoplasms

nafamostat has been researched along with Peritoneal Neoplasms in 2 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.

Research Excerpts

ExcerptRelevanceReference
"paclitaxel against gastric cancer with peritoneal dissemination by inhibiting NF-κB activation in mice."1.39Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice. ( Fujiwara, Y; Furukawa, K; Haruki, K; Iwase, R; Misawa, T; Ohashi, T; Shiba, H; Uwagawa, T; Yanaga, K, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiwara, Y2
Furukawa, K2
Haruki, K2
Shimada, Y1
Iida, T1
Shiba, H2
Uwagawa, T2
Ohashi, T2
Yanaga, K2
Iwase, R1
Misawa, T1

Other Studies

2 other studies available for nafamostat and Peritoneal Neoplasms

ArticleYear
Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition.
    Journal of hepato-biliary-pancreatic sciences, 2011, Volume: 18, Issue:5

    Topics: Animals; Benzamidines; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Enzym

2011
Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice.
    Digestive diseases and sciences, 2013, Volume: 58, Issue:1

    Topics: Animals; Antineoplastic Agents; Benzamidines; Caspase 3; Caspase 8; Cell Cycle; Cell Line, Tumor; Ce

2013